Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-28 @ 6:09 PM
Study NCT ID:
NCT04865458
Status:
UNKNOWN
Last Update Posted:
2022-05-06
First Post:
2021-04-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic Malignancies
Sponsor:
Sunshine Lake Pharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-26
First Submit QC Date:
None
Study First Post Date:
2021-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-05
Last Update Post Date:
2022-05-06
Last Update Post Date Type:
ACTUAL